Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0007 |
Cintirorgon
LYC-55716 |
ROR | Metabolism |
Cintirorgon (LYC-55716) 是一种首创的、口服有活力的的RORγ选择性激动剂。它通过调节 RORγ 表达的 T 淋巴免疫细胞的基因表达,提高效应子功能,降低免疫抑制,抑制肿瘤生长,提高生存率。 | |||
TQ0007L |
Cintirorgon sodium
LYC-55716 sodium salt,LYC 55716,LYC55716 |
||
Cintirorgon (LYC-55716) is an orally active RORgamma agonist with potential immunomodulatory and antineoplastic activities. LYC-55716 selectively binds to the RORg, and binds to ROR response elements, enhancing the function, proliferation, and survival of |